Corcept Therapeutics Cash from Other Financing Activities (Quarterly) Analysis

Corcept Therapeutics, Inc. (CORT)

35.02 +0.20 (+0.57%) USD | NASDAQ | Feb 23, 14:21

View Cash from Other Financing Activities (Quarterly) for CORT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Cash from Other Financing Activities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Cash from Other Financing Activities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Cash from Other Financing Activities (Quarterly) Benchmarks

Start Trial

Axsome Therapeutics, Inc.	Upgrade
United Therapeutics Corp.	Upgrade
Harrow, Inc.	Upgrade
Ultragenyx Pharmaceutical, Inc.	--
Amneal Pharmaceuticals, Inc.	Upgrade